Evidence map›Paper›PMID 41281216›Full record

ArticleArXiv2025

Low-N Protein Activity Optimization with FolDE.

Jacob B Roberts, Catherine R Ji, Isaac Donnell, Thomas D Young, Allison N Pearson, Graham A Hudson, Leah S Keiser, Mia Wesselkamper, Peter H Winegar, Janik Ludwig and 6 more

Abstract readPreprint
In one paragraph

Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jacob B RobertsJoint BioEnergy Institute, Emeryville, CA, USA.
Catherine R JiPrinceton University.
Isaac DonnellJoint BioEnergy Institute, Emeryville, CA, USA.
Thomas D YoungJoint BioEnergy Institute, Emeryville, CA, USA.
Allison N PearsonJoint BioEnergy Institute, Emeryville, CA, USA.
Graham A HudsonJoint BioEnergy Institute, Emeryville, CA, USA.
Leah S KeiserJoint BioEnergy Institute, Emeryville, CA, USA.
Mia WesselkamperJoint BioEnergy Institute, Emeryville, CA, USA.
Peter H WinegarJoint BioEnergy Institute, Emeryville, CA, USA.
Janik LudwigJoint BioEnergy Institute, Emeryville, CA, USA.
Sarah H KlassJoint BioEnergy Institute, Emeryville, CA, USA.
Isha V ShethJoint BioEnergy Institute, Emeryville, CA, USA.
Ezechinyere C UkabialaJoint BioEnergy Institute, Emeryville, CA, USA.
Maria C T AstolfiJoint BioEnergy Institute, Emeryville, CA, USA.
Benjamin EysenbachPrinceton University.
Jay D KeaslingJoint BioEnergy Institute, Emeryville, CA, USA.

Funding

Iterative Microbial Production and Systems Immunology to Design QS-21 AdjuvantsR01AI186111 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI JAY D KEASLING, Harshini Mukundan · 2024 to 2026
$2.6M
Biosynthesis of Cyclopamine and New-to-Nature Triterpenoids in YeastF32GM153046 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Peter Henry Winegar · 2024 to 2026
$229k
NIAID NIH HHS R01 AI186111NIGMS NIH HHS F32 GM153046
6 · The paper itself

Abstract

Proteins are traditionally optimized through the costly construction and measurement of many mutants. Active Learning-assisted Directed Evolution (ALDE) alleviates that cost by predicting the best improvements and iteratively testing mutants to inform predictions. However, existing ALDE methods face a critical limitation: selecting the highest-predicted mutants in each round yields homogeneous training data insufficient for accurate prediction models in subsequent rounds. Here we present FolDE, an ALDE method designed to maximize end-of-campaign success. In simulations across 20 protein targets, FolDE discovers 23% more top 10% mutants than the best baseline method (p=0.005) and is 55% more likely to find top 1% mutants. FolDE achieves this primarily through naturalness-based warm-starting, which augments limited activity measurements with protein language model outputs to improve activity prediction. We also introduce a constant-liar batch selector, which improves batch diversity; this is important in multi-mutation campaigns but had limited effect in our benchmarks. The complete workflow is freely available as open-source software, making efficient protein optimization accessible to any laboratory.

Indexed as

ALDELow-N Protein EngineeringReinforcement Learning

Identifiers

PMID41281216
PMCPMC12636759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.